Where is Bottneuro located?

Bottneuro AG, a spin-off of the University of Basel, is located on the Novartis Campus, Lichtstrasse 35, 4056 Basel, Switzerland.

When was Bottneuro founded?

Bottneuro was founded in 2021 in Basel, Switzerland.

What is Bottneuro's objective?

Bottneuro develops custom made neurostimulators and electroencephalogram devices for neurological conditions, such as Alzheimer's disease. Currently, there are 150,000 people affected by Alzheimer's disease in Switzerland, 1.5 million in Europe, and 6 million in the US.

Join Us in Pioneering Personalized Neurostimulation: Investment Opportunities in Round B

Empowering Neurological Therapies with Precision: At Bottneuro, a startup born out of the Department of Biomedical Engineering at the University of Basel, we stand at the forefront of neurological healthcare innovation. With our groundbreaking personalized neurostimulation technology, approved by Swissmedic and the MHRA in the UK as a tailor-made medical device, we are setting new standards in the treatment of neurological and psychiatric disorders. With the official registration of Bottneuro GmbH in Germany -our dedicated importer and subsidiary of Bottneuro AG in Switzerland- with EUDAMED our advanced neurological solutions can be delivered throughout the European Union.

A Global First in Patient Care: For the first time ever, our proprietary technology enables the application of fully personalized neurostimulation therapies for conditions such as Alzheimer's, depression, stroke, and other psychiatric disorders. Utilizing advanced MRI imaging, we can tailor treatments to the individual needs of each patient, a method prescribed and overseen by leading neurologists and psychiatrists.

Why Invest in Bottneuro? As we prepare for our next financial milestone, Round B, we invite visionary investors to join us in this exceptional journey. By investing in Bottneuro, you are not just funding a company; you're contributing to a revolution in personalized medicine that promises to transform the lives of millions suffering from neurological conditions worldwide.

Your Partnership in Innovation: We believe in transparent, collaborative growth, and are keen to share more about our technology, business model, and the profound impact we envision. Your investment will accelerate our mission, helping to expand our reach, enhance our technological capabilities, and ultimately, improve patient outcomes.

Connect with Us: To learn more about Bottneuro and the investment opportunities available in Round B, we warmly invite you to get in touch. Together, we can redefine the future of neurological care and make a lasting difference in the health and well-being of people around the globe.

Please contact us for further information and to explore how your investment can shape the future of neurostimulation therapy.

Are you interested in investing?

Backed by our private and institutional investors, we are advancing brain research to bring a new standard of care.

For more investment inquiries, please contact us at mail@bottneuro.ch